This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013

Stocks in this article: SLP MRK PFE AMGN INCY MO PG

MRK Dividend Yield (TTM) Chart

Merck (MRK) is a $169 billion global research-driven pharmaceutical company established in 1891.

Price to Book: 3.2

Forward Estimated Earnings Payout Percentage: 42%

Last week, the stock set a new 52-week high and is within bullish trend for the monthly, weekly and daily price charts. Trend followers love this type of price action and will stick with it until the trend changes.

Fundamentally, the company is an industry leader with an incredible revenue tailwind. The dividend remained at 38 cents per quarter from 2004 until 2011, when it was raised to 42 cents. Since then, the dividend has increased each year and is now 44 cents ($1.76 annualized) for a 3.1% yield.

Merck's pipeline of drugs include cancer (anti-PD1 immunotherapy for oncology) candidate MK-3475. Pfizer (PFE), Amgen (AMGN) and Incyte (INCY) signed three separate collaboration agreements with Merck earlier this year to study MK-3475.

The company's merger with Schering-Plough is paying off and accretive. According to the CEO Ken Frazier, $2.5 billion in further cost savings by 2016 is expected.

Merck's international sales are growing at a double-digit rate and produce about half of the revenue, diversifying the revenue stream across every significant market.

Analysts as a whole like this stock. Currently, Merck has 11 buy recommendations out of 20 analysts covering the company, along with 9 holds, and no analysts recommend selling. Analysts overall have called this one correctly. In the last 12 months, the shares have increased 21%. The average analyst current target price for Merck is $56.78.

Almost zero desire by short sellers to move against this stock. Short interest hardly moves the needle, with only 1% of the float. MRK Payout Ratio (TTM) Chart


2 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs